针对癌症治疗的精选的基因组甲基转移酶 (HMTs) 的小分子:目前的进展和新的策略
Deping Li1, Xiaopeng Peng2, Zhihao Hu2
1Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, PR China.
European journal of medicinal chemistry
|December 6, 2023
概括
基因组甲基转移酶 (HMTs) 是癌症的关键,但目前的抑制剂面临挑战. 像双位抑制剂和向蛋白质降解剂这样的新策略提供了改进的抗癌疗法.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 基因组甲基转移酶 (HMTs) 调节基因表达,在生理过程中至关重要.
- 包括EZH2,G9a,PRMT5和DOT1L在内的HMTs的失调与各种癌症有关.
- 传统的HMT抑制剂在临床疗效,选择性和耐药性方面存在局限性.
研究的目的:
- 审查基本HMTs的结构,功能和癌症相关性.
- 为突出 HMT 调节器开发用于癌症治疗的最新进展.
- 讨论基于HMT的药物发现的挑战和未来前景.
主要方法:
- 对HMTs (EZH2,G9a,PRMT5,DOT1L) 的文献综述及其在癌症中的作用.
- 对新型HMT调节剂的分析:双目标抑制剂,向蛋白质降解剂和共价抑制剂.
- 评估这些药物的合理设计,药理动力学,药理动力学和临床状态.
主要成果:
- 详细介绍了基本的HMT及其与各种癌症的具体联系.
- 新兴的HMT调节器显示出增强抗癌活性的潜力.
- 新的治疗策略解决了传统抑制剂的局限性.
结论:
- 在癌症治疗中,HMTs是有前途的治疗点.
- 创新方法对于克服HMT抑制剂开发方面的挑战至关重要.
- 对新型HMT调节器的进一步研究对未来的癌症疗法具有重大前景.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Histone Modification
3.4K
3.4K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


